Skip to main content
Top
Published in: Diabetologia 8/2012

Open Access 01-08-2012 | Article

High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes

Authors: L. J. M. Boonman-de Winter, F. H. Rutten, M. J. M. Cramer, M. J. Landman, A. H. Liem, G. E. H. M. Rutten, A. W. Hoes

Published in: Diabetologia | Issue 8/2012

Login to get access

Abstract

Aims/hypothesis

The aim of this study was to assess the prevalence of (unknown) heart failure and left ventricular dysfunction in older patients with type 2 diabetes.

Methods

In total, 605 patients aged 60 years or over with type 2 diabetes in the south west of the Netherlands participated in this cross-sectional study (response rate 48.7%), including 24 with a cardiologist-confirmed diagnosis of heart failure. Between February 2009 and March 2010, the patients without known heart failure underwent a standardised diagnostic work-up, including medical history, physical examination, ECG and echocardiography. An expert panel used the criteria of the European Society of Cardiology to diagnose heart failure.

Results

Of the 581 patients studied, 161 (27.7%; 95% CI 24.1%, 31.4%) were found to have previously unknown heart failure: 28 (4.8%; 95% CI 3.1%, 6.6%) with reduced ejection fraction, and 133 (22.9%; 95% CI 19.5%, 26.3%) with preserved ejection fraction. The prevalence of heart failure increased steeply with age. Heart failure with preserved ejection fraction was more common in women. Left ventricular dysfunction was diagnosed in 150 patients (25.8%; 95% CI 22.3%, 29.4%); 146 (25.1%; 95% CI 21.6%, 28.7%) had diastolic dysfunction.

Conclusions/interpretation

This is the first epidemiological study that provides exact prevalence estimates of (previously unknown) heart failure and left ventricular dysfunction in a representative sample of patients with type 2 diabetes. Previously unknown heart failure and left ventricular dysfunction are highly prevalent. Physicians should pay special attention to ‘unmasking’ these patients.
Literature
1.
go back to reference Blendea MC, McFarlane SI, Isenovic ER, Gick G, Sowers JR (2003) Heart disease in diabetic patients. Curr Diab Rep 3:223–229PubMedCrossRef Blendea MC, McFarlane SI, Isenovic ER, Gick G, Sowers JR (2003) Heart disease in diabetic patients. Curr Diab Rep 3:223–229PubMedCrossRef
2.
go back to reference Giles TD (2003) The patient with diabetes mellitus and heart failure: at-risk issues. Am J Med 115(Suppl 8A):107S–110SPubMedCrossRef Giles TD (2003) The patient with diabetes mellitus and heart failure: at-risk issues. Am J Med 115(Suppl 8A):107S–110SPubMedCrossRef
3.
go back to reference Giles TD, Sander GE (2004) Diabetes mellitus and heart failure: basic mechanisms, clinical features, and therapeutic considerations. Cardiol Clin 22:553–568PubMedCrossRef Giles TD, Sander GE (2004) Diabetes mellitus and heart failure: basic mechanisms, clinical features, and therapeutic considerations. Cardiol Clin 22:553–568PubMedCrossRef
4.
go back to reference Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DG, Struthers AD (1993) Echocardiography in chronic heart failure in the community. Q J Med 86:17–23PubMed Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DG, Struthers AD (1993) Echocardiography in chronic heart failure in the community. Q J Med 86:17–23PubMed
5.
go back to reference Rutten FH, Cramer MJ, Grobbee DE et al (2005) Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 26:1887–1894PubMedCrossRef Rutten FH, Cramer MJ, Grobbee DE et al (2005) Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 26:1887–1894PubMedCrossRef
6.
go back to reference Bertoni AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff DC Jr (2004) Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 27:699–703PubMedCrossRef Bertoni AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff DC Jr (2004) Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 27:699–703PubMedCrossRef
7.
go back to reference Nichols GA, Hillier TA, Erbey JR, Brown JB (2001) Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care 24:1614–1619PubMedCrossRef Nichols GA, Hillier TA, Erbey JR, Brown JB (2001) Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care 24:1614–1619PubMedCrossRef
8.
go back to reference Amato L, Paolisso G, Cacciatore F et al (1997) Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group. Diabetes Metab 23:213–218PubMed Amato L, Paolisso G, Cacciatore F et al (1997) Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group. Diabetes Metab 23:213–218PubMed
9.
go back to reference Thrainsdottir IS, Aspelund T, Thorgeirsson G et al (2005) The association between glucose abnormalities and heart failure in the population-based Reykjavik study. Diabetes Care 28:612–616PubMedCrossRef Thrainsdottir IS, Aspelund T, Thorgeirsson G et al (2005) The association between glucose abnormalities and heart failure in the population-based Reykjavik study. Diabetes Care 28:612–616PubMedCrossRef
10.
go back to reference Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB (2004) The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 27:1879–1884PubMedCrossRef Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB (2004) The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 27:1879–1884PubMedCrossRef
11.
go back to reference Davis RC, Hobbs FD, Kenkre JE et al (2002) Prevalence of left ventricular systolic dysfunction and heart failure in high risk patients: community based epidemiological study. BMJ 325:1156PubMedCrossRef Davis RC, Hobbs FD, Kenkre JE et al (2002) Prevalence of left ventricular systolic dysfunction and heart failure in high risk patients: community based epidemiological study. BMJ 325:1156PubMedCrossRef
12.
go back to reference Boonman-de Winter LJ, Rutten FH, Cramer MJ et al (2009) Early recognition of heart failure in patients with diabetes type 2 in primary care. A prospective diagnostic efficiency study. (UHFO-DM2). BMC Public Health 9:479PubMedCrossRef Boonman-de Winter LJ, Rutten FH, Cramer MJ et al (2009) Early recognition of heart failure in patients with diabetes type 2 in primary care. A prospective diagnostic efficiency study. (UHFO-DM2). BMC Public Health 9:479PubMedCrossRef
13.
go back to reference Rose GA, Blackburn H (1968) Cardiovascular survey methods. Monogr Ser World Health Organ 56:1–188PubMed Rose GA, Blackburn H (1968) Cardiovascular survey methods. Monogr Ser World Health Organ 56:1–188PubMed
14.
go back to reference Schiller NB, Shah PM, Crawford M et al (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358–367PubMed Schiller NB, Shah PM, Crawford M et al (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358–367PubMed
15.
go back to reference Folland ED, Parisi AF, Moynihan PF, Jones DR, Feldman CL, de Tow (1979) Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques. Circulation 60:760–766PubMedCrossRef Folland ED, Parisi AF, Moynihan PF, Jones DR, Feldman CL, de Tow (1979) Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques. Circulation 60:760–766PubMedCrossRef
16.
go back to reference Quinones MA, Waggoner AD, Reduto LA et al (1981) A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 64:744–753PubMedCrossRef Quinones MA, Waggoner AD, Reduto LA et al (1981) A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 64:744–753PubMedCrossRef
17.
go back to reference Willenheimer RB, Israelsson BA, Cline CM, Erhardt LR (1997) Simplified echocardiography in the diagnosis of heart failure. Scand Cardiovasc J 31:9–16PubMedCrossRef Willenheimer RB, Israelsson BA, Cline CM, Erhardt LR (1997) Simplified echocardiography in the diagnosis of heart failure. Scand Cardiovasc J 31:9–16PubMedCrossRef
18.
go back to reference Freeman AP, Giles RW, Walsh WF, Fisher R, Murray IP, de Wilcken (1985) Regional left ventricular wall motion assessment: comparison of two-dimensional echocardiography and radionuclide angiography with contrast angiography in healed myocardial infarction. Am J Cardiol 56:8–12PubMedCrossRef Freeman AP, Giles RW, Walsh WF, Fisher R, Murray IP, de Wilcken (1985) Regional left ventricular wall motion assessment: comparison of two-dimensional echocardiography and radionuclide angiography with contrast angiography in healed myocardial infarction. Am J Cardiol 56:8–12PubMedCrossRef
19.
go back to reference Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613–618PubMedCrossRef Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613–618PubMedCrossRef
20.
go back to reference Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB (2002) Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 90:1284–1289PubMedCrossRef Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB (2002) Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 90:1284–1289PubMedCrossRef
21.
go back to reference Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463PubMedCrossRef Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463PubMedCrossRef
22.
go back to reference Yock PG, Popp RL (1984) Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 70:657–662PubMedCrossRef Yock PG, Popp RL (1984) Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 70:657–662PubMedCrossRef
23.
go back to reference Munagala VK, Jacobsen SJ, Mahoney DW, Rodeheffer RJ, Bailey KR, Redfield MM (2003) Association of newer diastolic function parameters with age in healthy subjects: a population-based study. J Am Soc Echocardiogr 16:1049–1056PubMedCrossRef Munagala VK, Jacobsen SJ, Mahoney DW, Rodeheffer RJ, Bailey KR, Redfield MM (2003) Association of newer diastolic function parameters with age in healthy subjects: a population-based study. J Am Soc Echocardiogr 16:1049–1056PubMedCrossRef
24.
go back to reference Bursi F, Weston SA, Redfield MM et al (2006) Systolic and diastolic heart failure in the community. JAMA 296:2209–2216PubMedCrossRef Bursi F, Weston SA, Redfield MM et al (2006) Systolic and diastolic heart failure in the community. JAMA 296:2209–2216PubMedCrossRef
25.
go back to reference Paulus WJ, Tschope C, Sanderson JE et al (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28:2539–2550PubMedCrossRef Paulus WJ, Tschope C, Sanderson JE et al (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28:2539–2550PubMedCrossRef
26.
go back to reference Gottdiener JS, Bednarz J, Devereux R et al (2004) American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 17:1086–1119PubMed Gottdiener JS, Bednarz J, Devereux R et al (2004) American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 17:1086–1119PubMed
27.
go back to reference Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442PubMedCrossRef Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442PubMedCrossRef
28.
go back to reference Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M (1972) Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med 287:781–787PubMedCrossRef Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M (1972) Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med 287:781–787PubMedCrossRef
29.
go back to reference Fischer M, Baessler A, Hense HW et al (2003) Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 24:320–328PubMedCrossRef Fischer M, Baessler A, Hense HW et al (2003) Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 24:320–328PubMedCrossRef
30.
go back to reference Diamant M, Lamb HJ, Smit JW, de Roos A, Heine RJ (2005) Diabetic cardiomyopathy in uncomplicated type 2 diabetes is associated with the metabolic syndrome and systemic inflammation. Diabetologia 48:1669–1670PubMedCrossRef Diamant M, Lamb HJ, Smit JW, de Roos A, Heine RJ (2005) Diabetic cardiomyopathy in uncomplicated type 2 diabetes is associated with the metabolic syndrome and systemic inflammation. Diabetologia 48:1669–1670PubMedCrossRef
31.
go back to reference Kardys I, Deckers JW, Stricker BH, Vletter WB, Hofman A, Witteman J (2010) Distribution of echocardiographic parameters and their associations with cardiovascular risk factors in the Rotterdam Study. Eur J Epidemiol 25:481–490PubMedCrossRef Kardys I, Deckers JW, Stricker BH, Vletter WB, Hofman A, Witteman J (2010) Distribution of echocardiographic parameters and their associations with cardiovascular risk factors in the Rotterdam Study. Eur J Epidemiol 25:481–490PubMedCrossRef
32.
go back to reference Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107–133PubMedCrossRef Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107–133PubMedCrossRef
33.
go back to reference Moons KG, de Grobbee (2002) When should we remain blind and when should our eyes remain open in diagnostic studies? J Clin Epidemiol 55:633–636PubMedCrossRef Moons KG, de Grobbee (2002) When should we remain blind and when should our eyes remain open in diagnostic studies? J Clin Epidemiol 55:633–636PubMedCrossRef
34.
go back to reference Bossuyt PM, Reitsma JB, Bruns DE et al (2003) The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 49:7–18PubMedCrossRef Bossuyt PM, Reitsma JB, Bruns DE et al (2003) The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 49:7–18PubMedCrossRef
35.
go back to reference Rutten FH, Moons KG, Cramer MJ et al (2005) Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 331:1379PubMedCrossRef Rutten FH, Moons KG, Cramer MJ et al (2005) Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 331:1379PubMedCrossRef
36.
go back to reference Hogg K, Swedberg K, McMurray J (2004) Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 43:317–327PubMedCrossRef Hogg K, Swedberg K, McMurray J (2004) Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 43:317–327PubMedCrossRef
37.
go back to reference Henry RM, Paulus WJ, Kamp O et al (2008) Deteriorating glucose tolerance status is associated with left ventricular dysfunction–the Hoorn Study. Neth J Med 66:110–117PubMed Henry RM, Paulus WJ, Kamp O et al (2008) Deteriorating glucose tolerance status is associated with left ventricular dysfunction–the Hoorn Study. Neth J Med 66:110–117PubMed
38.
go back to reference Paulus WJ, van Ballegoij JJ (2010) Treatment of heart failure with normal ejection fraction: an inconvenient truth! J Am Coll Cardiol 55:526–537PubMedCrossRef Paulus WJ, van Ballegoij JJ (2010) Treatment of heart failure with normal ejection fraction: an inconvenient truth! J Am Coll Cardiol 55:526–537PubMedCrossRef
39.
go back to reference Satpathy C, Mishra TK, Satpathy R, Satpathy HK, Barone E (2006) Diagnosis and management of diastolic dysfunction and heart failure. Am Fam Physician 73:841–846PubMed Satpathy C, Mishra TK, Satpathy R, Satpathy HK, Barone E (2006) Diagnosis and management of diastolic dysfunction and heart failure. Am Fam Physician 73:841–846PubMed
40.
go back to reference American Diabetes Association (2010) Standards of medical care in diabetes–2010. Diabetes Care 33(Suppl 1):S11–S61CrossRef American Diabetes Association (2010) Standards of medical care in diabetes–2010. Diabetes Care 33(Suppl 1):S11–S61CrossRef
Metadata
Title
High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes
Authors
L. J. M. Boonman-de Winter
F. H. Rutten
M. J. M. Cramer
M. J. Landman
A. H. Liem
G. E. H. M. Rutten
A. W. Hoes
Publication date
01-08-2012
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 8/2012
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-012-2579-0

Other articles of this Issue 8/2012

Diabetologia 8/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.